Product Recalls: September 16, 2026-October 14, 2026
Health Letter, November 2026
Note: Never stop taking a drug that appears on the product recall list without first talking to your doctor or pharmacist. Most recalls are limited to a single manufacturer and may not be related to the version of a particular drug you are taking. If a recall does relate to the version of the drug you are taking, you should not stop taking the drug until you discuss an alternative treatment with your doctor or pharmacist.
CLASS I
thyroid tablets, 1/2 grain (30 mg); each tablet contains: levothyroxine (T4) 19 mcg, liothyronine (T3) 4.5 mcg; 100 tablets. Distributed by: Vitruvias Therapeutics. Lot #: 504950, exp. date: 09/30/2026.
CLASS II
chlorthalidone tablets, 25 mg, 100 tablets per bottle. Manufactured by: Inventia Healthcare Limited. Batch #: RISA24002, exp. date: 04/2027.
paroxetine extended-release tablets, 37.5 mg, 30-count bottle. Manufactured by: Apotex Inc. Lot #: TY9495, exp. date: 05/2027.
ranolazine extended-release tablets, 1,000 mg, 60-count bottle. Marketed by: Ajanta Pharma USA Inc. Lot #: DJ25134, exp. date: 11/30/2028.
For more information about the drug recalls listed above, please visit http://www.accessdata.fda.gov/scripts/ires/index.cfm.
CONSUMER PRODUCTS
For a list of recent recalls of consumer products, please visit the Consumer Product Safety Commission website at http://www.cpsc.gov/en/Recalls/.